Product Description
Ref-SKU:
006V-03026 Glc5 is introduced in LCMV-GP thus mimicking LASV glycosylation. rLCMV+Glc5 is ≥100-fold less sensitive to KL25 or WEN3 neutralization than WT virus.
Product Risk Group:
ICTV Taxonomy:
Virus name:
Subspecies:
Storage conditions:
Ethanol -80C
Sequencing:
Partial sequence
Infectivity:
Infectivity tested and quantified
Mycoplasmic content:
Mycoplasma free
GMO:
No
Biosafety restrictions:
BSL2
Virus host type:
Infectivity Test:
Plaque forming assay
Production cell line:
Virus Cultivability:
Passage:
P1
Identification technique:
Plaque forming assay
Shipping conditions:
IATA Classification:
Information about the collection of the virus
Recombinant product:
This product is a recombinant product
Biological material origin:
Synthetic origin
Synthetic part identification: LCMV Cl13, L segment
Synthetic part identification:
LCMV Cl13, L segment
Genbank reference:
Modifications from the reference sequence(s):
The sequence(s) of this synthetic product has NOT been modified from the sequence listing provided as Genbank references
Synthetic part identification: LCMV WE-GP
Synthetic part identification:
LCMV WE-GP
Genbank reference:
Modifications from the reference sequence(s):
The sequence(s) of this synthetic product has been modified from the sequence listing provided as Genbank references
Description of modification(s) made from the reference sequence(s):
10.1371/journal.ppat.1005276
Synthetic part identification: LCMV Cl13, S segment (without GP)
Synthetic part identification:
LCMV Cl13, S segment (without GP)
Genbank reference:
Modifications from the reference sequence(s):
The sequence(s) of this synthetic product has been modified from the sequence listing provided as Genbank references
Description of modification(s) made from the reference sequence(s):
GP of Cl13 has been replaced by WE-GP